AI-generated content for educational purposes only. Not tax advice. Citations may contain errors — verify independently.
← Back to corpus

Management Fee Waivers: Prospective Capital Gain or Disguised Compensation?

⚡ Advisor-Initiated Very High
—
🛡️ Senior Advisor 2026-04-09 14:00
Thank you both for making time on short notice. I asked for this meeting because we need to talk about your management fee waiver arrangement — the one that converts a portion of your management fee into carried interest. The IRS issued new guidance three months ago that's creating real audit risk for these structures, and I've seen two funds in similar situations get hit with reclassification adjustments in the last quarter. If the IRS successfully reclassifies your waived fees back to ordinary income, you're looking at a rate differential of roughly 17 points — 37% ordinary rates versus the 20% long-term capital gains rate you've been reporting on that income. On a $2 million annual fee waiver, that's $340,000 per year in additional tax exposure, and the lookback period could go back three years. The new guidance focuses heavily on whether the waiver was prospective, whether it was documented before services were rendered, and whether the GP is receiving anything economically different from a fee. I pulled your partnership agreement last week, and there are some provisions in there that concern me — specifically around the timing and discretion language. Sarah, I'd like to walk through what the IRS is actually looking at in these audits, and then we can talk about whether a voluntary amendment makes sense here or whether we think your current structure holds up. What's your initial reaction to revisiting this?
🏢 Client 2026-04-09 14:00
Look, I appreciate the heads-up, but I'm skeptical. We put this fee waiver structure in place four years ago with a Big Four firm that charged us a fortune to document it properly. Now you're telling me we need to spend more money and time to fix something that was supposedly bulletproof? What's the actual trigger here? You mentioned new guidance three months ago — is this a revenue ruling, a change in regs, or just the IRS deciding to audit more aggressively? Because if it's just enforcement posture and not a change in law, I'm not sure I want to preemptively blow up a structure that's been working fine. And let's be practical about timing. We're in the middle of fundraising for Fund IV, I've got an LP advisory board meeting in two weeks, and our CFO is slammed with K-1 prep. If we're going to revisit this, I need to understand what's actually broken and why it can't wait until after we close the fund. What exactly did the IRS say that makes our current documentation inadequate?
⚡ Junior Advisor 2026-04-09 14:00
I've reviewed the guidance your senior colleague is referring to, and I think we need to separate two issues here. The first is whether your existing arrangement is defensible under current law — and honestly, I'm less concerned than he is. The second is whether the IRS's current enforcement posture creates enough audit risk to justify the disruption of an amendment during your fundraise. The guidance he's referencing is Rev. proc. 93-27, which has been on the books for decades, and the recent IRS focus has been on applying the existing rules more aggressively — not changing the rules themselves. The core test is still whether the waiver was made before the services were rendered and whether you're receiving a genuine profits interest rather than a disguised fee. If your Big Four firm structured this correctly four years ago, the documentation should show a prospective waiver with the capital interest allocated at formation or before the service period began. The IRS wins these cases when the waiver is retroactive or when the arrangement looks economically identical to just taking the fee and buying in — but that's a facts-and-circumstances analysis, not a bright-line rule that changed three months ago. Here's what I need to see before we talk about amendments: the actual waiver language in your partnership agreement, the capital account allocations from the year you implemented this, and any side letters or management company agreements that describe how the fee calculation works. If the waiver is genuinely prospective and the carried interest allocation was made before you performed the services, I think your structure holds up under audit — and the cost of defending it is a lot less than the cost of restructuring mid-fundraise. Sarah, can you get me those documents today so I can give you a definitive read on whether your existing structure is actually at risk?
🏢 Client 2026-04-09 14:00
I need to understand the cost-benefit here before I pull people off critical path work. Let's say we do nothing and the IRS audits us — what does that fight actually cost? Are we talking about a $50,000 legal bill to defend a position that you think is solid, or are we talking about a multi-year examination that costs half a million in fees and management distraction? And if we do amend the structure now, what's involved? I'm not rewriting the entire partnership agreement while we're in the market raising capital. Are we talking about a straightforward amendment that takes two weeks and doesn't require LP consent, or are we talking about something that triggers LPAC approval and raises questions with prospective investors about why we're changing our economics mid-fundraise? Because here's my concern: if the existing structure is genuinely defensible and the worst case is we spend some money in three years defending an audit, that's a very different risk than what your senior colleague is suggesting. But if the amendment is quick, cheap, and doesn't disrupt the fundraise, then maybe it's worth doing just to take the issue off the table. I need actual numbers on both scenarios — what does defense cost, what does amendment cost, and what's the realistic probability the IRS even looks at this given everything else they could be auditing?
⚡ Junior Advisor 2026-04-09 14:01
I think you're asking exactly the right questions, but the cost-benefit calculation here depends on something we haven't nailed down yet — whether your current documentation is actually vulnerable or whether my colleague is being overly cautious. A Big Four firm four years ago should have documented a prospective waiver under Rev. Proc. 93-27, but I've seen situations where the documentation looks fine at formation and then gets undermined by how the arrangement actually operates year-to-year. If your partnership agreement says the waiver is prospective but your management company is making annual elections about how much to waive, that creates a fact pattern the IRS will attack — and defending that is expensive because it's a facts-and-circumstances fight, not a clean legal issue. On audit defense costs, if the documentation is clean and the IRS challenge is purely about applying settled law to good facts, you're probably looking at $75,000 to $150,000 in professional fees to get through examination and potentially Appeals — that assumes we don't go to Tax Court. But if the facts are ambiguous — if there's discretion being exercised year-to-year or if the economics look too much like a fee — you're looking at $300,000-plus and a realistic risk that we lose, which means you're paying the defense costs and the tax deficiency. The IRS knows these arrangements are lucrative to challenge because the dollar amounts are large and a lot of funds would rather settle than litigate. Here's what I disagree with in the approach my colleague is taking: he's assuming the IRS guidance from three months ago changed your risk profile, but I don't think it did. The law hasn't changed — enforcement posture has. If your structure was defensible four months ago, it's defensible now, and the question is whether the documentation supports the tax treatment you've been taking. Before we talk about amendments or costs, I need to see whether the waiver in your agreement is truly prospective or whether there's year-to-year discretion that creates exposure. Can you send me the partnership agreement and the last two years of management company board resolutions or fee waiver elections so I can tell you whether we're defending a strong position or a weak one?
🛡️ Senior Advisor 2026-04-09 14:01
I need to push back on something my colleague just said, because I think he's underestimating what's actually happening in these audits. He's right that the law hasn't changed — Rev. Proc. 93-27 has been around since 1993 — but the IRS examination teams are now coordinating with the Office of Chief Counsel on these cases, and they're taking much more aggressive positions on what counts as "prospective." I've seen two examinations in the last four months where the IRS argued that an annual confirmation of the waiver — even when the partnership agreement authorized it in advance — created a year-to-year election that destroyed the prospective nature of the arrangement. They're not just reading the partnership agreement anymore; they're deposing the CFO and the general counsel about how decisions actually got made, and if there's any evidence that the GP discussed whether to waive in a given year, they're arguing it's retroactive. The problem with waiting to see the documents before we assess risk is that Sarah needs to make a business decision now about whether to disrupt the fundraise, and that decision can't wait for us to do a three-day document review and then discover there's a problem. What I saw in your partnership agreement last week was a provision that says the management company "may elect" to waive fees for a given year — and that language is exactly what the IRS is attacking in these other audits, regardless of whether the election was contemplated at formation. If we've got that kind of discretion language in the agreement, we need to talk about an amendment now, because defending "may elect" language is not a $75,000 problem — it's a $300,000 problem with a real risk of losing. Sarah, here's the decision you're facing: do we spend two weeks now doing a narrow amendment that removes the discretion language and replaces it with a fixed waiver formula, which probably doesn't require LP consent because it's reducing GP economics, not increasing them? Or do we wait, hope we don't get audited in the next three years, and potentially face a much bigger problem during your Fund IV hold period when you need clean tax returns to exit portfolio companies? What's your tolerance for that timing risk?
⚡ Junior Advisor 2026-04-09 14:01
I need to see that provision before we tell Sarah she has a problem, because "may elect" language is not automatically fatal — it depends on what the election is tied to and whether it's genuinely prospective. Rev. Proc. 93-27 allows a partner to receive a profits interest in exchange for services if the interest is granted before the services are performed, but it doesn't prohibit the partnership agreement from containing conditional or formulaic language about how much of the profits interest is allocated based on future performance. The IRS wins when the GP is making a retroactive decision about whether to take a fee or convert it after the services are already rendered and the value is known — that's a disguised sale. But if the partnership agreement says "the management company may elect annually to waive up to X% of its management fee in exchange for a corresponding increase in carried interest, provided such election is made before the beginning of the calendar year," that's a prospective waiver with a formulaic condition, not a retroactive recharacterization. What I'm hearing from you is that the IRS is taking aggressive positions in audits, but that doesn't mean they're winning those positions, and it definitely doesn't mean Sarah should preemptively amend a structure that might be completely defensible. The cost of an amendment right now isn't just the legal bill — it's the risk that prospective LPs see a mid-fundraise change to GP economics and start asking why we're reducing our skin in the game, or worse, whether there's a tax problem we're trying to fix. If we amend now and it turns out the original structure was fine, we've created fundraising friction for no reason. Here's what I think we owe Sarah before she makes this decision: a two-hour review of the actual waiver provision, the capital account mechanics, and how the elections have been documented over the last four years. If the waiver is genuinely prospective and the only issue is that the IRS might argue it's not, that's a risk Sarah can choose to take with eyes open. But if there's something in the documents that's actually inconsistent with Rev. Proc. 93-27 — if the waiver is happening after the service period or if the economics are identical to a fee — then we need to fix it regardless of the fundraise timing. Can we spend today and tomorrow doing that review before we advise Sarah to amend anything?
🛡️ Senior Advisor 2026-04-09 14:02
I appreciate that you want to do a careful document review, and normally I'd agree with you — but we're not in a normal timing situation, and I think you're missing the strategic issue here. Sarah is in the middle of a fundraise, which means her tax returns for the last three years are going to be in the data room for prospective LPs to review. If we do a document review this week and discover there's a problem, we're now sitting on a known tax risk during fundraising, and Sarah has a disclosure obligation to prospective investors. That's a much worse position than addressing it proactively before anyone's asking questions. The other issue is that the IRS doesn't care whether we think "may elect" language is prospective — they care whether it gives the GP discretion after the service period starts, and the examination teams I've dealt with are treating any annual decision point as evidence of retroactivity. You're technically right that a formulaic waiver with a pre-year election can qualify under Rev. Proc. 93-27, but the burden is on us to prove that's how it actually operated, and if the CFO can't produce board minutes showing the election was made in December for the following year, we lose that argument. I don't know whether Sarah's management company has been documenting annual elections that way, but in my experience most funds haven't, because their Big Four advisors told them the partnership agreement language was sufficient and they didn't need separate annual paperwork. Here's what I'm proposing: we do the document review you're asking for, but we do it this week with the assumption that if we find ambiguity, we're amending before the end of the month. That way Sarah can make an informed decision, but we're not creating a situation where we identify a risk and then sit on it while Fund IV investors are doing diligence. Does that work for you, or do you think the existing structure is strong enough that we can wait and defend it later even if there's some discretion language in the agreement?
🏢 Client 2026-04-09 14:02
I'm going to stop you both right there, because this is exactly the kind of advisor debate that costs me money without answering my question. You two need to get aligned on the facts before you bring me options. Here's what I'm hearing: one of you thinks we have a serious problem that needs fixing now, and the other thinks we might be fine but wants to review documents first. That tells me neither of you actually knows whether my structure is broken. And your senior guy just said if we do the review and find a problem, I've got a disclosure issue in the data room — which means the review itself creates risk I don't have today if I just sit tight. So here's what I need, and I need it by end of week: pull the partnership agreement, pull every document related to how we've actually operated the fee waiver for the last four years, and come back with a single recommendation. Not two options, not a hedge — tell me whether you think the current structure survives an audit or not. If you think it doesn't, fine, we'll talk about amendment timing and LP disclosure. If you think it does, then I want to understand what I'm paying to defend and what the realistic probability of audit is, because I'm not fixing something that isn't broken just because the IRS is being more aggressive in other cases. And one more thing — if we do amend, I need to know exactly what we're disclosing to Fund IV investors and how we're positioning it, because if this looks like we're fixing a tax screwup mid-fundraise, that's a bigger problem than the IRS risk. Get me a clear answer by Friday.
⚡ Junior Advisor 2026-04-09 14:02
I think we can get you that answer by Friday, but I need to be direct about something: the review we're proposing will not create a disclosure obligation you don't already have. If there's a tax position that doesn't comply with Rev. Proc. 93-27, that risk exists today whether we look at the documents or not, and you already have an obligation to disclose material tax risks to prospective LPs in the data room. What the review does is let you disclose accurately — either "our structure complies with applicable guidance and we're comfortable defending it" or "we've identified an issue and amended the arrangement to eliminate the risk." Ignoring the question doesn't make the risk go away; it just means you're taking a position in your data room without knowing whether it's supportable. Here's where I disagree with my colleague's framing: he's assuming that any discretion language creates a fatal problem, but that's not consistent with how Rev. Proc. 93-27 actually works. The revenue procedure requires that the profits interest be granted in connection with services to be performed — it doesn't require that every economic term be fixed at formation with zero flexibility. If your partnership agreement gives the management company the right to waive a specified percentage of fees each year in exchange for a corresponding increase in carry, and that right was granted at formation before any services were performed, that's a prospective waiver. The question is whether the annual implementation of that right looks like a new decision about past services or just the mechanical operation of a formula that was already agreed. I'll pull the documents today and we'll have a recommendation by Friday, but I want to set expectations: if the partnership agreement has clear prospective language and the only issue is whether you documented board minutes for each year's waiver, that's a procedural fix we can address going forward without amending the partnership agreement or disclosing anything to Fund IV investors. Is that the level of specificity you need, or are you asking us to make a broader risk tolerance call about whether to defend this structure even if the facts are slightly ambiguous?
🛡️ Senior Advisor 2026-04-09 14:03
I'm going to disagree with you on the disclosure point, because you're conflating two different things. Sarah doesn't have an obligation to disclose every position the IRS might theoretically challenge — she has an obligation to disclose material tax risks that would affect an LP's investment decision. If we do a document review this week and conclude that the fee waiver structure has a 30% chance of being recharacterized on audit, that's absolutely a material risk she needs to disclose, because it affects the after-tax economics of the GP's carry and potentially the fund's ability to execute cleanly on exits. Right now, she can truthfully say the structure was implemented by a Big Four firm and she's relying on that advice — once we red-flag it internally, that reliance defense gets weaker and the disclosure obligation gets stronger. The bigger problem is that you're still treating this like a binary question — does it comply or doesn't it — when the reality is these cases turn on facts and circumstances that make them expensive to defend even when we think we're right. I've been through three of these audits in the last two years, and in every single one the IRS examination team brought in an economist to argue that the waived fee arrangement was economically indistinguishable from just taking the fee and buying a profits interest, regardless of what the partnership agreement said. We won two of those cases, but it cost $200,000-plus in professional fees and took eighteen months, and the third one settled because the client didn't want the distraction during a fundraise — which is exactly the situation Sarah's in now. Here's what I think we owe Sarah by Friday: not just whether the documents technically comply with Rev. Proc. 93-27, but whether the structure is defensible enough that we'd recommend fighting an audit during Fund IV's investment period, or whether the prudent move is to clean it up now while she has time. Sarah, does that frame the question correctly, or are you purely asking whether the current structure is legally supportable regardless of what it costs to defend?
🏢 Client 2026-04-09 14:03
Alright, here's what we're doing. We'll run the full document review by Friday, and if you two come back and tell me the structure is defensible — meaning you'd be comfortable fighting the audit even if it costs $200,000 — then we sit tight and I accept the risk that the IRS challenges this in three years when it's maximally disruptive. I understand that even if we're technically right, the fight itself is expensive and the outcome isn't guaranteed, and I'm willing to live with that if the alternative is spooking Fund IV investors mid-raise. Get me the recommendation Friday morning, and if we're amending, I'll have our fund counsel draft the partnership amendment and the LP disclosure language over the weekend so we can button this up before the next data room goes out.
🔍 IRS Examiner 2026-04-09 14:03
# INTERNAL REVENUE SERVICE ## EXAMINATION MEMORANDUM **EXAMINATION DIVISION:** Large Business & International – Pass-Through Entities **ISSUE SPECIALIST:** Partnership Allocations & Disguised Payments for Services **TAXPAYER:** [Private Equity Fund General Partner] **TAX YEARS:** 2022, 2023, 2024 --- ### I. ISSUE The taxpayer converted a portion of annual management fees into carried interest (profits interest) pursuant to a partnership agreement provision permitting annual fee waivers. The taxpayer reported the waived fees as long-term capital gain allocations taxed at 20%, rather than ordinary compensation income taxed at 37%. The government contends this arrangement constitutes a disguised payment for services under Section 707(a)(2)(A) and Treasury Regulation Section 1.707-2, resulting in underreported ordinary income of approximately $2 million annually. --- ### II. GOVERNMENT'S POSITION The fee waiver arrangement fails the requirements of Rev. Proc. 93-27 because the partnership agreement grants the management company discretionary authority to elect annually whether to waive fees, creating a year-to-year determination made after services are substantially rendered. The provision stating the GP "may elect" to waive fees for a given year demonstrates that the waiver decision occurs during or after the service period, not prospectively before services are performed. This annual discretion converts what should be treated as a prospective profits interest grant into a retroactive recharacterization of compensation already earned, which is precisely the type of arrangement Section 707(a)(2)(A) is designed to capture. The economic substance of the arrangement is indistinguishable from the GP receiving the full management fee and then purchasing a profits interest with after-tax dollars, except the taxpayer avoided the ordinary income tax that should have applied to the compensation component. --- ### III. PROPOSED ADJUSTMENT The government will recharacterize the waived management fees as ordinary compensation income taxable under Section 61(a)(1) and Section 707(a) for each examination year. For tax year 2024, this results in additional ordinary income of $2,000,000, taxed at the maximum individual rate of 37%, producing additional tax liability of $740,000 compared to the $400,000 reported at the 20% long-term capital gain rate—a deficiency of $340,000 for that year alone. Accuracy-related penalties under Section 6662(a) at 20% would apply to the portion of the underpayment attributable to substantial understatement of income tax, adding approximately $68,000 per year. Extending the examination to the full three-year statute of limitations period produces total proposed deficiencies exceeding $1,000,000 plus penalties and interest. --- ### IV. BEST SUPPORTING AUTHORITY **IRC Section 707(a)(2)(A)**: Provides that if a partner performs services for a partnership and there is a related direct or indirect allocation and distribution to the partner, the transaction shall be treated as occurring between the partnership and one who is not a partner if the arrangement, when viewed together with the allocation and distribution, is properly characterized as a transaction between the partnership and a partner acting other than in his capacity as a member of the partnership. **Treasury Regulation Section 1.707-2(c)**: States that an allocation fails to be respected as a profits interest if it is part of an arrangement whereby a partner transfers money or property to a partnership and receives a related allocation and distribution that, when viewed together, are properly characterized as a disguised sale or disguised payment for services. The determination depends on all facts and circumstances, including whether the timing and amount of the allocation are reasonably contingent on the partner's services. **Rev. Proc. 93-27, Section 3.01**: Permits a partner to receive a profits interest for services without immediate taxation only if the interest is granted for services to be provided to or for the benefit of the partnership in a partner capacity. The safe harbor applies only when the profits interest relates to future partnership profits, not to a recharacterization of payments that economically represent current compensation. Courts have applied substance-over-form principles in partnership taxation since *Commissioner v. Culbertson*, 337 U.S. 733 (1949), examining whether the allocation of partnership income reflects the economic arrangement or merely serves to convert ordinary income into capital gain. --- ### V. WEAKNESSES The taxpayer will argue that the fee waiver provision was documented in the original partnership agreement before services commenced, satisfying the "prospective" requirement, and that annual implementation of a pre-agreed formula does not constitute retroactive recharacterization.
Quality Review 4.6 / 5 by Vera
▾
Citation Accuracy 5
Fact Pattern 5
Advisor Disagreement 5
Client Realism 5
IRS Examiner 5
Educational Value 4
Pitch Quality
4/5
⚠ Flagged Citations None flagged. Rev. Proc. 93-27 is correctly cited and applicable. IRC § 707(a)(2)(A), Treas. Reg. § 1.707-2(c), IRC § 6662(a), and Commissioner v. Culbertson, 337 U.S. 733 (1949) are all real and properly applied.
What Worked The advisor disagreement is exceptionally strong—two sophisticated practitioners arguing genuinely different risk assessments on the same facts, with both positions having clear merit. The Junior's technical parsing of Rev. Proc. 93-27's prospective requirement versus the Senior's practical focus on current IRS examination tactics creates productive tension. The Client's frustration ("this is exactly the kind of advisor debate that costs me money") and demand for a unified recommendation feels authentic. The IRS examination memo is outstanding—specific proposed adjustment with dollar amounts, proper statutory framework, and acknowledgment of taxpayer's likely defense.
Discussion

Sign in to join the discussion.

Sign in or Create account
No comments yet. Be the first.